Stifel raises Boston Scientific stock target to $120, keeps buy rating
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...
Bisnow10d
Where 3 Boston Real Estate CEOs Are Targeting Investments This Year
The heads of The RMR Group, Lupoli Cos. and National Development share their investment and development priorities for 2025.
Investing24d
Boston Omaha reports equity securities sale
The sale of equity securities was conducted under ... set to run through September 2025. Boston Omaha has made substantial investments exceeding $490 million, which TD Cowen expects to yield ...
PFG Investments LLC Increases Stake in Boston Scientific Co. (NYSE:BSX)
PFG Investments LLC boosted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities ...
Business Insider26d
TMDX SHAREHOLDER ALERT: TransMedics Group Investigated for Securities Fraud; Contact Block & Leviton to Discuss Your Rights
Boston, Massachusetts ... for potential securities law violations. Investors who have lost money in their TransMedics Group, Inc. investment should contact the firm to learn more about how ...
Investing24d
Boston Omaha reports equity securities sale
The sale of equity securities was conducted under an exemption ... set to run through September 2025. Boston Omaha has made substantial investments exceeding $490 million, which TD Cowen expects to ...